Kinase insert domain receptor

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from KDR/Flk-1)
Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.



Kinase insert domain receptor (a type III receptor tyrosine kinase)
Identifiers
Symbol(s) KDR; CD309; FLK1; VEGFR; VEGFR2
External IDs OMIM: 191306 MGI96683 Homologene55639
RNA expression pattern

Image:PBB GE KDR 203934 at tn.png

More reference expression data

Orthologs
Human Mouse
Entrez 3791 16542
Ensembl ENSG00000128052 ENSMUSG00000062960
Uniprot P35968 Q3UQZ6
Refseq NM_002253 (mRNA)
NP_002244 (protein)
XM_984991 (mRNA)
XP_990085 (protein)
Location Chr 4: 55.64 - 55.69 Mb Chr 5: 76.21 - 76.26 Mb
Pubmed search [2] [3]

Kinase insert domain receptor (a type III receptor tyrosine kinase), also known as KDR, is a human gene.



See also

Further reading

  • Petrova TV, Makinen T, Alitalo K (1999). "Signaling via vascular endothelial growth factor receptors.". Exp. Cell Res. 253 (1): 117-30. doi:10.1006/excr.1999.4707. PMID 10579917.
  • Sato Y, Kanno S, Oda N, et al. (2000). "Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.". Ann. N. Y. Acad. Sci. 902: 201-5; discussion 205-7. PMID 10865839.
  • Zachary I, Gliki G (2001). "Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.". Cardiovasc. Res. 49 (3): 568-81. PMID 11166270.
  • Vené R, Benelli R, Noonan DM, Albini A (2001). "HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis.". Clin. Exp. Metastasis 18 (7): 533-8. PMID 11688957.
  • Lenton K (2003). "VEGFR-2 (KDR/Flk-1).". J. Biol. Regul. Homeost. Agents 16 (3): 227-32. PMID 12456025.
  • Matsumoto T, Mugishima H (2006). "Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.". J. Atheroscler. Thromb. 13 (3): 130-5. PMID 16835467.
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools